Abayon, Romeo L.

HRN: 22-11-33  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2022
CEFUROXIME 1.5GM (VIAL)
10/24/2022
10/31/2022
IVT
1.5g
Q8hours
Indirect Inguinal Hernia
Waiting Final Action 
10/24/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/24/2022
10/31/2022
IVT
500mg
Q8hours
Indirect Hernia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: